These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 16042985

  • 1. Endothelin-1 contributes to the sexual differences in renal damage in DOCA-salt rats.
    Montezano AC, Callera GE, Mota AL, Fortes ZB, Nigro D, Carvalho MH, Zorn TM, Tostes RC.
    Peptides; 2005 Aug; 26(8):1454-62. PubMed ID: 16042985
    [Abstract] [Full Text] [Related]

  • 2. Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension.
    Kawanishi H, Hasegawa Y, Nakano D, Ohkita M, Takaoka M, Ohno Y, Matsumura Y.
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):280-5. PubMed ID: 17324138
    [Abstract] [Full Text] [Related]

  • 3. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms.
    Callera GE, Tostes RC, Yogi A, Montezano AC, Touyz RM.
    Clin Sci (Lond); 2006 Feb; 110(2):243-53. PubMed ID: 16271043
    [Abstract] [Full Text] [Related]

  • 4. Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats.
    David FL, Carvalho MH, Cobra AL, Nigro D, Fortes ZB, Rebouças NA, Tostes RC.
    Hypertension; 2001 Sep; 38(3 Pt 2):692-6. PubMed ID: 11566958
    [Abstract] [Full Text] [Related]

  • 5. ETA receptor mediates altered leukocyte-endothelial cell interaction and adhesion molecules expression in DOCA-salt rats.
    Callera GE, Montezano AC, Touyz RM, Zorn TM, Carvalho MH, Fortes ZB, Nigro D, Schiffrin EL, Tostes RC.
    Hypertension; 2004 Apr; 43(4):872-9. PubMed ID: 14993193
    [Abstract] [Full Text] [Related]

  • 6. Reduced NO production rapidly aggravates renal function through the NF-κB/ET-1/ETA receptor pathway in DOCA-salt-induced hypertensive rats.
    Kimura K, Ohkita M, Koyama M, Matsumura Y.
    Life Sci; 2012 Oct 15; 91(13-14):644-50. PubMed ID: 22569294
    [Abstract] [Full Text] [Related]

  • 7. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
    Allcock GH, Venema RC, Pollock DM.
    Am J Physiol; 1998 Jul 15; 275(1):R245-52. PubMed ID: 9688985
    [Abstract] [Full Text] [Related]

  • 8. Effect of pravastatin on nephroprotection in deoxycorticosterone acetate-salt hypertensive rats.
    Kang CS, Chang NC, Chang ST, Lin CC, Lee TM.
    J Hypertens; 2009 Nov 15; 27(11):2232-43. PubMed ID: 19812503
    [Abstract] [Full Text] [Related]

  • 9. Global upregulation of gene expression associated with renal dysfunction in DOCA-salt-induced hypertensive rats occurs via signaling cascades involving epidermal growth factor receptor: a microarray analysis.
    Benter IF, Canatan H, Benboubetra M, Yousif MH, Akhtar S.
    Vascul Pharmacol; 2009 Nov 15; 51(2-3):101-9. PubMed ID: 19410658
    [Abstract] [Full Text] [Related]

  • 10. Low NaCl intake elevates renal medullary endothelin-1 and endothelin A (ETA) receptor mRNA but not the sensitivity of renal Na+ excretion to ETA receptor blockade in rats.
    Klinger F, Grimm R, Steinbach A, Tanneberger M, Kunert-Keil C, Rettig R, Grisk O.
    Acta Physiol (Oxf); 2008 Mar 15; 192(3):429-42. PubMed ID: 17892519
    [Abstract] [Full Text] [Related]

  • 11. Increased renal medullary endothelin-1 synthesis in prehypertensive DOCA- and salt-treated rats.
    Hsieh TJ, Lin SR, Lee YJ, Shin SJ, Lai YH, Hsu CH, Tsai JH.
    Am J Physiol Renal Physiol; 2000 Jul 15; 279(1):F112-21. PubMed ID: 10894793
    [Abstract] [Full Text] [Related]

  • 12. The effect of estrogen on serum nitric oxide concentrations in normotensive and DOCA Salt hypertensive ovariectomized rats.
    Nematbakhsh M, Khazaei M.
    Clin Chim Acta; 2004 Jun 15; 344(1-2):53-7. PubMed ID: 15149870
    [Abstract] [Full Text] [Related]

  • 13. Increased reactive oxygen species contributes to kidney injury in mineralocorticoid hypertensive rats.
    Jin L, Beswick RA, Yamamoto T, Palmer T, Taylor TA, Pollock JS, Pollock DM, Brands MW, Webb RC.
    J Physiol Pharmacol; 2006 Sep 15; 57(3):343-57. PubMed ID: 17033089
    [Abstract] [Full Text] [Related]

  • 14. Polyphenols restore endothelial function in DOCA-salt hypertension: role of endothelin-1 and NADPH oxidase.
    Jiménez R, López-Sepúlveda R, Kadmiri M, Romero M, Vera R, Sánchez M, Vargas F, O'Valle F, Zarzuelo A, Dueñas M, Santos-Buelga C, Duarte J.
    Free Radic Biol Med; 2007 Aug 01; 43(3):462-73. PubMed ID: 17602962
    [Abstract] [Full Text] [Related]

  • 15. Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension.
    Klanke B, Cordasic N, Hartner A, Schmieder RE, Veelken R, Hilgers KF.
    Nephrol Dial Transplant; 2008 Nov 01; 23(11):3456-63. PubMed ID: 18515791
    [Abstract] [Full Text] [Related]

  • 16. Role of endothelins in hypertension.
    Feldstein C, Romero C.
    Am J Ther; 2007 Nov 01; 14(2):147-53. PubMed ID: 17414582
    [Abstract] [Full Text] [Related]

  • 17. Nephroprotective effects of the endothelin ET(A) receptor antagonist darusentan in salt-sensitive genetic hypertension.
    Rothermund L, Traupe T, Dieterich M, Kossmehl P, Yagil C, Yagil Y, Kreutz R.
    Eur J Pharmacol; 2003 May 16; 468(3):209-16. PubMed ID: 12754059
    [Abstract] [Full Text] [Related]

  • 18. Ameliorating effect of an endothelin ETA receptor antagonist on renal function of DOCA-salt hypertensive rats.
    Matsumura Y, Hashimoto N, Fujita K, Morimoto S.
    Eur J Pharmacol; 1997 Jan 14; 319(1):65-9. PubMed ID: 9030899
    [Abstract] [Full Text] [Related]

  • 19. Chronic treatment with mianserin prevents DOCA-salt hypertension in rats--evidence for the involvement of central 5-HT2 receptors.
    Silva AL, Cabral AM, Abreu GR, Pires JG, Bissoli NS, Ramage AG.
    Eur J Pharmacol; 2005 Aug 22; 518(2-3):152-7. PubMed ID: 16014306
    [Abstract] [Full Text] [Related]

  • 20. Role of endothelin and endothelin receptor antagonists in renal disease.
    Neuhofer W, Pittrow D.
    Eur J Clin Invest; 2006 Sep 22; 36 Suppl 3():78-88. PubMed ID: 16919017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.